Argenica Therapeutics Seeks New Securities Quotation
Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited, identified by ASX issuer code AGN, has announced the application for quotation of 589,041 new fully paid ordinary securities on June 14, 2024. This move indicates a potential expansion or fundraising effort by the company, which could be of interest to current and prospective investors.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.